Silo Pharma Expands into AI Agent Market with Qwikagents Acquisition
Silo Pharma, Inc. has announced a major strategic shift, expanding its business into artificial intelligence through the acquisition of the AI platform Qwikagents. The move signals the company’s entry into the rapidly growing AI agent market, which analysts project could reach over $50 billion by 2030.
The newly acquired platform, Qwikagents.ai, is designed to deploy autonomous AI agents capable of performing tasks such as research, content generation, scheduling, and workflow automation. With built-in smart-routing technology, the platform aims to optimize performance and cost efficiency across multiple AI models—positioning it as a scalable solution for both businesses and individual users.
According to CEO Eric Weisblum, the expansion into AI infrastructure is intended to diversify revenue streams and align the company with emerging high-growth technologies. He emphasized that AI agents are becoming a core component of modern digital ecosystems, making this a timely investment.
As part of the transition, Silo Pharma has established a dedicated AI subsidiary that will manage Qwikagents and oversee future developments in AI-related technologies. Despite the pivot, the company confirmed it remains committed to its core biopharmaceutical pipeline, including its PTSD treatment candidate SPC-15, which is currently being prepared for Phase 1 clinical trials pending regulatory approval from the U.S. Food and Drug Administration.
Industry forecasts suggest strong momentum for AI agents, with multiple research firms estimating annual growth rates between 43% and 50%. This reflects increasing demand for automation tools that can streamline operations and enhance productivity across industries.
Silo Pharma’s entry into the AI sector highlights a broader trend of companies diversifying into artificial intelligence as they seek new growth opportunities. However, as with many emerging technologies, the long-term success of such ventures will depend on execution, market adoption, and the company’s ability to compete in an increasingly crowded AI landscape.
